Cargando…
Novel coronavirus mutations: Vaccine development and challenges
The ongoing global pandemic of novel coronavirus pneumonia (COVID-19) caused by the SARS-CoV-2 has a significant impact on global health and economy system. In this context, there have been some landmark advances in vaccine development. Over 100 new coronavirus vaccine candidates have been approved...
Autores principales: | Luo, Wan-Rong, Wu, Xiao-Min, Wang, Wei, Yu, Jun-Ling, Chen, Qing-Qing, Zhou, Xue, Huang, Xin'er, Pan, Hai-Feng, Liu, Zhi-Rong, Gao, Yong, He, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561474/ https://www.ncbi.nlm.nih.gov/pubmed/36243381 http://dx.doi.org/10.1016/j.micpath.2022.105828 |
Ejemplares similares
-
mRNA cancer vaccines: Advances, trends and challenges
por: He, Qing, et al.
Publicado: (2022) -
The Epidemiological Pattern and Co-infection of Influenza A and B by Surveillance Network From 2009 to 2014 in Anhui Province, China
por: He, Jun, et al.
Publicado: (2022) -
Stormorken Syndrome Caused by a Novel STIM1 Mutation: A Case Report
por: Jiang, Li-Jun, et al.
Publicado: (2021) -
Changes in Serum Neutralizing Antibodies Levels During Convalescence of COVID-19 Patients
por: Chen, Qing-Qing, et al.
Publicado: (2022) -
A localized small-scale external quality assessment (EQA) for PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the molecular laboratories
por: Li, Rong-Hai, et al.
Publicado: (2022)